Company / R&D Expense
CONMED Corporation R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$55.9M
FY2025
5-year range
$40.5M / $55.9M
FY2021-FY2025
Trend
+2.7%
vs FY2024
Sector context
#75 of 110
Health Care
What the data says
At $56M, CONMED Corporation's r&d expense ranks #75 of 110 in the Health Care sector. R&D Expense has increased for 3 consecutive years, from $40M in FY2022 to $56M in FY2025.
Based on SEC 10-K filings.
$56M in FY2025 with a 5-year CAGR of +5.8%.
Improved from $53M to $56M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +11.4%
- 5-Year CAGR
- +5.8%
- 10-Year CAGR
- -
Sector benchmark
#75 of 110 in Health CareTop 68% of 110This company $55.9M Sector average $298.2M
▼
-81.3% below sector average
Key checks
Key Insights
- CONMED Corporation's r&d expense has grown for 3 consecutive years.
- 5-year CAGR of +5.8%, indicating consistent growth.
- In FY2025, r&d expense increased 2.7% year-over-year.
- Ranks #75 out of 110 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $55.9M | +2.7% |
| FY2024 | $54.4M | +3.5% |
| FY2023 | $52.6M | +30.0% |
| FY2022 | $40.5M | -11.0% |
| FY2021 | $45.5M | +7.8% |
| FY2020 | $42.2M | +30.6% |
| FY2019 | $32.3M | +0.2% |
| FY2018 | $32.3M | +17.6% |
| FY2017 | $27.4M | -1.2% |
| FY2016 | $27.8M | +1.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026